Anna Sicuranza

Residual Peripheral Blood CD26+ Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission

Monica Bocchia, Anna Sicuranza, Elisabetta Abruzzese et al. · Frontiers in Oncology · 2018 · 105 citations · Full text

Medicine, Hematology, Oncology +17

Flow Cytometry Assessment of CD26⁺ Leukemic Stem Cells in Peripheral Blood: A Simple and Rapid New Diagnostic Tool for Chronic Myeloid Leukemia

Donatella Raspadori, Paola Pacelli, Anna Sicuranza et al. · Cytometry Part B Clinical Cytometry · 2019 · 43 citations · Full text

Medicine, Hematology, Pathology +17

Venetoclax in association with decitabine as effective bridge to transplant in a case of relapsed early T‐cell lymphoblastic leukemia

Elisabetta Zappone, Emanuele Cencini, Marzia Defina et al. · Clinical Case Reports · 2020 · 31 citations · Full text

Medicine, Hematology, Pharmacology +13

Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients

Monica Bocchia, Sara Galimberti, Lara Aprile et al. · Oncotarget · 2016 · 29 citations · Full text

Medicine, Hematology, Pharmacology +13

The Slower Antibody Response in Myelofibrosis Patients after Two Doses of mRNA SARS-CoV-2 Vaccine Calls for a Third Dose

Fabio Fiorino, Anna Sicuranza, Annalisa Ciabattini et al. · Biomedicines · 2021 · 28 citations · Full text

Veterinary Medicine, Immunology, Molecular Medicine +15